Latest News about Gene Therapy
Recent news which mentions Gene Therapy
Applied Genetic's Vision Loss Gene Therapy Shows Encouraging Safety, Efficacy At Three Months
May 17, 2022
Tickers
AGTC
From Benzinga
Adverum Bio Posts Additional Efficacy, Safety Data From ADVM-022 Gene Therapy In Wet AMD
May 02, 2022
Tickers
ADVM
From Benzinga
Monitoring Board Gives Positive Recommendation On Ocugen's Eye Disease Gene Therapy Trial
April 25, 2022
Tickers
OCGN
From Benzinga
From PRUnderground
From Benzinga
From Benzinga
Takeda Inks $2B Gene Therapy Pact With Code Biotherapeutics
February 22, 2022
From Benzinga
FDA Asks For More Data To Resolve BioMarin's Gene Therapy Clinical Hold
February 18, 2022
Tickers
BMRN
From Benzinga
RegenXBio Posts Updated Data From Hunter Syndrome Gene Therapy Trial
February 09, 2022
Tickers
RGNX
From Benzinga
After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data
February 09, 2022
Tickers
AVRO
From Benzinga
Sangamo Therapeutics Shares Updated Interim Data From Fabry Disease Gene Therapy Trial
February 08, 2022
Tickers
SGMO
From Benzinga
Sio Gene Terminates Parkinson's Gene Therapy Pact With Oxford Biomedica, Announces CEO Transition
February 01, 2022
Tickers
SIOX
From Benzinga
Taysha Reports Efficacy, Safety Data From High Dose Cohort For Neurological Disorder Gene Therapy Trial
January 31, 2022
Tickers
TSHA
From Benzinga
From Benzinga
FDA Pushes Review Period For Bluebird bio's Neurodegenerative Disease, Thalassemia Gene Therapies
January 18, 2022
Tickers
BLUE
From Benzinga
Pfizer's Duchenne Gene Therapy Trial Put On FDA Hold After Patient Death
December 21, 2021
Tickers
PFE
From Benzinga
Adverum Outlines Development Plan For ADVM-022 Gene Therapy In Wet AMD
December 21, 2021
Tickers
ADVM
From Benzinga
Bluebird bio's Neurodegenerative Disease Gene Therapy Under Priority FDA Review, Despite Clinical Hold
December 20, 2021
Tickers
BLUE
From Benzinga
UniQure Shares Fall After Clinical Update From Huntington's Disease Gene Therapy Trial
December 16, 2021
Tickers
QURE
From Benzinga
New Data At ASH21 Show Bluebird's Thalassemia Gene Therapy Potentially Curative One-Time Treatment
December 13, 2021
Tickers
BLUE
From Benzinga
Bluebird Bio Posts Updated Data From Sickle Cell Gene Therapy Program
December 13, 2021
Tickers
BLUE
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.